EUVIMEDEUVIMED entdecken
Crossref

Patent Challenges And Litigation On Inhalers For Asthma And COPD

Sanjay Reddy, Reed F Beall, S Sean Tu, Aaron S Kesselheim, William B Feldman

Health Affairs · 2023

DOI: 10.1377/hlthaff.2022.00873 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Affairs, 2023. Verfasst von Sanjay Reddy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sanjay Reddy, Georgetown University, Washington, D.C. Hauptthemen laut MEDLINE: Asthma, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaPulmonary Disease, Chronic ObstructiveUnited StatesHumansDrugs, GenericDrug ApprovalNebulizers and Vaporizers

Substanzen

Drugs, Generic

Autor:innen und Institutionen

  • Sanjay Reddy, Georgetown University, Washington, D.C.
  • Reed F. Beall, University of Calgary, Calgary, Alberta, Canada.
  • S. Sean Tu, University of West Virginia, Morgantown, West Virginia.
  • Aaron S. Kesselheim, Brigham and Women's Hospital and Harvard University, Boston, Massachusetts.
  • William B. Feldman (wbfeldman@bwh.harvard.edu), Brigham and Women's Hospital and Harvard University.

Zitieren

APA

Reddy, S., Beall, R. F., Tu, S. S., Kesselheim, A. S., & Feldman, W. B. (2023). Patent Challenges And Litigation On Inhalers For Asthma And COPD. Health Affairs. https://doi.org/10.1377/hlthaff.2022.00873

Vancouver

Reddy S, Beall RF, Tu SS, Kesselheim AS, Feldman WB. Patent Challenges And Litigation On Inhalers For Asthma And COPD. Health Affairs. 2023. doi:10.1377/hlthaff.2022.00873

BibTeX
@article{Reddy2023,
  author = {Reddy, Sanjay and Beall, Reed F and Tu, S Sean and Kesselheim, Aaron S and Feldman, William B},
  title = {Patent Challenges And Litigation On Inhalers For Asthma And COPD},
  journal = {Health Affairs},
  year = {2023},
  doi = {10.1377/hlthaff.2022.00873}
}
Kostenlos starten →